Valuation: Cellnovo

Market Cap 24.36L 21.73L 20.24L 18.42L 34.69L 23Cr 34.95L 2.45Cr 95.17L 12Cr 91.43L 89.46L 38Cr P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 1.25Cr 1.11Cr 1.04Cr 94.22L 1.77Cr 119.98Cr 1.79Cr 13Cr 4.87Cr 61Cr 4.68Cr 4.58Cr 196.83Cr EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 26.79L
+1.44%+3.40%-0.39%+64.87% 3,84300Cr
+0.25%+1.04%+5.52%+1,098.20% 45TCr
+0.20%+7.84%-50.96%+31.97% 43TCr
+0.83%+3.37%+90.67%+242.36% 33TCr
+1.15%+4.98%+119.51%+558.62% 28TCr
+0.61%+0.55%-20.10%+51.50% 24TCr
+1.02%+3.28%-25.64%+24.06% 14TCr
+1.69%+4.28%+112.86%+216.91% 13TCr
+0.85%+2.47%+74.97%+207.49% 9.95TCr
Average +0.83%+2.40%+34.05%+277.33% 59.45TCr
Weighted average by Cap. +1.17%+1.25%+9.44%+178.47%

Financials

2018 2019 *
Net sales 33.22L 29.63L 27.61L 25.12L 47.31L 32Cr 47.67L 3.34Cr 1.3Cr 16Cr 1.25Cr 1.22Cr 52Cr -
Net income -1.59Cr -1.42Cr -1.32Cr -1.21Cr -2.27Cr -153.5Cr -2.29Cr -16Cr -6.23Cr -78Cr -5.98Cr -5.85Cr -251.83Cr -
Net Debt 1Cr 89.41L 83.3L 75.8L 1.43Cr 97Cr 1.44Cr 10Cr 3.92Cr 49Cr 3.76Cr 3.68Cr 158.35Cr -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock